-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor’s name and address for Baxter Pharmaceutical Products, Inc.
DATES:
This rule is effective September 5, 2001.
ADDRESSES:
Lonnie W. Luther, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0209.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Baxter Pharmaceutical Products, Inc., 110 Allen Rd., Liberty Corner, NJ 07938, has informed FDA of a change of name and address to Baxter Healthcare Corp., 95 Spring St., New Providence, NJ 07974. Accordingly, the agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2) to reflect the changes.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 510
End List of SubjectsAdministrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.
Start Amendment PartTherefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:
End Amendment Part Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part Start Amendment Part2. Section 510.600 is amended in the table in paragraph (c)(1) by revising the entry for “Baxter Pharmaceutical Products, Inc.” and in the table in paragraph (c)(2) by revising the entry for “010019” to read as follows:
End Amendment PartNames, addresses, and drug labeler codes of sponsors of approved applications.* * * * *(c) * * *
(1) * * *
Firm name and address Drug labeler code * * * * * * * Baxter Healthcare Corp., 95 Spring St., New Providence, NJ 07974 010019 * * * * * * * (2) * * *
Start Printed Page 46368Start SignatureDrug labeler code Firm name and address * * * * * * * 010019 Baxter Healthcare Corp., 95 Spring St., New Providence, NJ 07974 * * * * * * * Dated: August 23, 2001.
Claire M. Lathers,
Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 01-22167 Filed 9-4-01; 8:45 am]
BILLING CODE 4160-01-S
Document Information
- Effective Date:
- 9/5/2001
- Published:
- 09/05/2001
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 01-22167
- Dates:
- This rule is effective September 5, 2001.
- Pages:
- 46367-46368 (2 pages)
- PDF File:
- 01-22167.pdf
- CFR: (1)
- 21 CFR 510.600